¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023 ´ëÇѾฮÇÐȸ Á¦75Â÷ Ãß°èÇмú´ëȸ(2ÀÏÂ÷) : 2023-11-07

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023 ´ëÇѾฮÇÐȸ Á¦75Â÷ Ãß°èÇмú´ëȸ(2ÀÏÂ÷) : 2023-11-07
±³À°ÀÏÀÚ : 2023-11-07
±³À°Àå¼Ò : ´ëÀüÄÁº¥¼Ç¼¾ÅÍ Á¦1Àü½ÃÀå 2Ãþ ±×·£µåº¼·ë, 204-205È£

±³À°ÁÖÁ¦ : 2023 ´ëÇѾฮÇÐȸ Á¦75Â÷ Ãß°èÇмú´ëȸ(2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѾฮÇÐȸ
´ã´çÀÚ : ½Å¼öÀÎ
¿¬¶ôó : 02-326-0370  

À̸ÞÀÏ : head@kosphar.org

±³À°Á¾·ù : »ý¸®ÇÐ, ¾à¸®ÇÐ

Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 11 ½Ã°£ 28ºÐ

¼¼ºÎ¼ö°­·á : 150,000¿ø  

ºñ°í ÆòÀÇ¿ø & Á¤È¸¿ø 15¸¸¿ø, ÁØȸ¿ø (Çлýȸ¿ø) 8¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 09:00~09:20 Comprehensive genomic characterization of Korean advanced pan-cancer patients facilitates personalized »ç°æÇÏ(°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 09:20~09:40 Building human single-cell atlas for disease modelling and cell engineering ¹ÚÁ¾Àº(KAIST ÀÇ°úÇдëÇпø)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 09:40~10:00 Metabolic and functional adaptation of T cells in the tumor microenvironment ÀÓ¼±¾Æ(ÀÌÈ­¿©ÀÚ´ëÇб³ »ý¸í°úÇаú)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 10:00~10:20 Application of single cell mega-atlas in drug target and biomarker discovery ¹ÚÁöȯ(GIST »ý¸í°úÇкÎ)

ÈÞ½Ä 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 10:20~10:30 ÈÞ½Ä ()

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 10:30~11:10 Acquired epithelial WNT secretion drives niche independence of developing gastric cancer ±¸º»°æ(IBS)

Åä·Ð 11¿ù 07ÀÏ 207-211È£ 11:10~12:00 Poster Presentation ()

½Ä»ç 11¿ù 07ÀÏ 204-205È£ 12:00~13:00 ÆòÀÇ¿øȸ & ½Ä»ç ¸íâ¼±(Ãæ³²´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 13:00~13:20 Successful Drug Repositioning for Rare Genetic Disease À̹üÈñ(¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 13:20~13:40 The role of TET enzymes in Cancer Immunotherapy ¼­Çü¼®(¼­¿ï´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 13:40~14:00 Divalent oligonucleotides are bioavailable in the lung and efficiently block SARS-CoV-2 infection ½Å¹Î¿í(¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 14:00~14:20 CLDN18.2-targeting ADC for gastric cancers prepared by AbClick¢â Pro Á¤»óÀü(¼º±Õ°ü´ëÇб³ ¾àÇдëÇÐ)

ÈÞ½Ä 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 14:20~14:30 ÈÞ½Ä ()

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 14:30~15:10 The Interactions between eosinophils and mast cells (THE Allergic Effector Unit)as the ultimate pro-inflammatory cross-talk? Francesca Levi-Schaffer(Hebrew University of Jerusalem, Israel)

ÈÞ½Ä 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 15:10~15:20 ÈÞ½Ä ()

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 15:20~15:50 SREBP-1c regulates hepatic fibrosis via regulating lipocalin-2 expression in NASH Àӽ¼ø(°è¸í´ë ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 15:50~16:20 Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis Á¤¿µ¹Ì(ºÎ»ê´ëÇб³ ÀÚ¿¬°úÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 16:20~16:50 New roles of G12 family proteins in cellular metabolisms ±èÅÂÇö(¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 16:50~17:20 Understanding of human diseases in fuel metabolismperspective using the state-of-the art-metabolomicstechniques ÃÖµ¿¿í(°í·Á´ëÇб³ »ý¸í°øÇкÎ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 09:00~09:20 The functional analysis of DDX41 in DNA damage response pathway ±èÈ«ÅÂ(UNIST)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 09:20~09:40 Role of HDAC6 in induced resistance of NSCLCs against radiation therapy ±è¿ì¿µ(¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇкÎ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 09:40~10:00 Mechanisms that limit replication fork stress and genomic instability ±â¿µÈÆ(DGIST)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 10:00~10:20 Bromodomain proteins are protectors against endogenous DNA damage ±èÀçÁø(ÇѸ²´ëÇб³ »ý¸í°úÇаú)

ÈÞ½Ä 11¿ù 07ÀÏ 204-205È£ 10:20~11:10 ÈÞ½Ä ()

½Ä»ç 11¿ù 07ÀÏ 204-205È£ 12:00~13:00 ÆòÀÇ¿øȸ & ½Ä»ç ¸íâ¼±(Ãæ³²´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 13:00~13:13 Successful Drug Repositioning for Rare Genetic Disease ·ùÁÖÈñ(¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 13:13~13:26 The role of TET enzymes in Cancer Immunotherapy À±¼Ò¹Ì(¼­¿ï´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 13:26~13:39 Divalent oligonucleotides are bioavailable in the lung and efficiently block SARS-CoV-2 infection ÇÑÁÖÈñ(¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 13:39~13:52 CLDN18.2-targeting ADC for gastric cancers prepared by AbClick¢â Pro ½Å¹Î±Ô(¼º±Õ°ü´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 13:52~14:05 Optical sensing and control of protein activity for the study of brain diseases ¼ºÁöÇý(¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 14:05~14:18 First-in-Human Study of J2H-1702, a Novel 11¥â-hydroxysteroid Dehydrogenase Type 1 Inhibitor ÀÌ»ó¿ø(ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ)

ÈÞ½Ä 11¿ù 07ÀÏ 204-205È£ 14:18~15:20 ÈÞ½Ä ()

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 15:20~15:50 SREBP-1c regulates hepatic fibrosis via regulating lipocalin-2 expression in NASH °­Á¾¼ø(¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 15:50~16:20 Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis À±¹Ì¼·(°¡Ãµ´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 16:20~16:50 New roles of G12 family proteins in cellular metabolisms ±èÇö¿ì(KAIST »ý¸í°úÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 16:50~17:20 Understanding of human diseases in fuel metabolismperspective using the state-of-the art-metabolomicstechniques ¹è±Ô¿î(¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇдëÇÐ)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023 ´ëÇѾฮÇÐȸ Á¦75Â÷ Ãß°èÇмú´ëȸ(2ÀÏÂ÷) : 2023-11-07""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °æ»ó±¹¸³´ëÇб³º´¿ø ¼­ºÎ°æ³² À̺ñÀÎÈÄ°ú Áý´ãȸ : 2023-11-08
´ÙÀ½±Û 2023³âµµ ºÐ´ç¼­¿ï´ëÇб³º´¿ø Á¤½Å°Ç°­ÀÇÇаú ¿¬¼ö°­Á : 2023-11-07
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20775 ¼­¿ï 2024³â °áÇÙ°ü¸®±³À° 1±â(1ÀÏÂ÷) : 2024-06-13 0 3 2024-05-27
20774 ºÎ»ê (¿Â¶óÀÎ) ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ ºÎ»ê¡¤¿ï»ê¡¤°æ³² ÁöºÎȸ 2024³â 06¿ù Çмú´ëȸ : 2024-06-13 0 5 2024-05-27
20773 ´ëÀü 2024 Á¦40ȸ ´ëÇѼҾƿܰúÇÐȸ Ãá°èÇмú´ëȸ ¹× 40Áֳ⠱â³äÇà»ç(1ÀÏÂ÷) : 2024-06-13 0 3 2024-05-27
20772 ´ë±¸ 2024 Á¦2Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ ´ë±¸°æºÏÁöºÎÇÐȸ : 2024-06-13 0 8 2024-05-27
20771 ¼­¿ï ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (1ÀÏÂ÷) : 2024-06-13 0 11 2024-05-27
20770 ¼­¿ï 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(1ÀÏÂ÷) : 2024-06-13 0 4 2024-05-27
20769 ¼­¿ï 2024³â ±Ýõ±¸ÀÇ»çȸ 1Â÷ ¿¬¼ö±³À°(¿ì¿ïÁõ ¾àÁ¦, ÇǺÎÁúȯ, CBC¿Í LFT, À§¿°) : 2024-06-12 0 2 2024-05-27
20768 ¼­¿ï 2024 Á¦3ȸ ÀÌ°ÇÈñ ¼Ò¾Æ¾Ï¡¤Èñ±ÍÁúȯ ±Øº¹»ç¾÷ ¿¬±¸ÀÚ SKILL-UP Workshop : 2024-06-12 0 2 2024-05-27
20767 °æ±â ´ëÇÑÇǺΰúÇÐȸ Á¦78Â÷ °æ±âÁöºÎȸ ÇмúÁý´ãȸ : 2024-06-11 0 2 2024-05-27
20766 ±¤ÁÖ Á¦180Â÷ ´ëÇѼҾÆû¼Ò³â°úÇÐȸ ±¤ÁÖ¡¤Àü³²Áöȸ ÇмúÁý´ãȸ : 2024-06-11 0 6 2024-05-27
20765 ºÎ»ê ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ºÎ»ê,¿ï»ê,°æ³²Áöȸ - Á¦362Â÷ ¿ù·ÊÇмúȸ : 2024-06-11 0 11 2024-05-27
20764 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-06-11 0 6 2024-05-27
20763 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ(ÀÇ»ç) ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À° : 2024-06-11 0 14 2024-05-27
20762 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆÀÀ±ÞÀÇÇÐȸ Á¦ 32ȸ Á¤±â Áý´ãȸ : 2024-06-10 0 10 2024-05-27
20761 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø Á¦16ȸ KOALA Symposium 2024 : 2024-06-09 0 2 2024-05-27
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷